about
Protective effect of EDTA preadministration on renal ischemiaSimultaneous administration of insulin-like growth factor-1 and darbepoetin alfa protects the rat myocardium against myocardial infarction and enhances angiogenesisPromises and pitfalls in erythopoietin-mediated tissue protection: are nonerythropoietic derivatives a way forward?The challenge of translating ischemic conditioning from animal models to humans: the role of comorbidities.Effect of erythropoietin on the expression of dynamin-related protein-1 in rat renal interstitial fibrosis.Carbamylated erythropoietin ameliorates the metabolic stress induced in vivo by severe chronic hypoxiaThe diabetic heart: too sweet for its own good?Role of ATP-dependent K channels in the effects of erythropoietin in renal ischaemia injuryThe role of erythropoietin in myocardial protection: potential mechanisms and applications.Ischemic preconditioning in solid organ transplantation: from experimental to clinics.Pharmacological enhancement of neuronal survival.Multiorgan-protective actions of blockers of the renin-angiotensin system, statins and erythropoietin: common pleiotropic effects in reno-, cardio- and neuroprotection.Occult cardiotoxicity--toxic effects on cardiac ischemic tolerance.Cardiovascular effects of erythropoietin an update.Erythropoietin: a hormone with multiple functions.Genetics and genomics of ischemic tolerance: focus on cardiac and cerebral ischemic preconditioning.Ischaemic conditioning strategies for the nephrologist: a promise lost in translation?Mechanism of cardioprotective effect of erythropoietin-induced preconditioning in rat heartRole of heme oxygenase-1 in the cardioprotective effects of erythropoietin during myocardial ischemia and reperfusion.Erythropoietin pretreatment protects against acute chemotherapy toxicity in isolated rat hearts.Pretreatment with erythropoietin attenuates the neurological injury after spinal cord ischemia.Ischemic preconditioning protects the dog kidney from ischemia-reperfusion injury.Pyruvate is a prospective alkalizer to correct hypoxic lactic acidosis.The magic mountain or death in Venice: chronic hypoxia may alleviate oxidative stress in the kidney.An overview of protective strategies against ischemia/reperfusion injury: The role of hyperbaric oxygen preconditioning.Reply to Abdelwahid and Smith: The effect on cardiomyocytes of helix B-surface peptide (HBSP), a peptide with cell-protective but not erythropoietic activities of erythropoietin.
P2860
Q33236469-A1C2E4E5-362E-4FB9-BD33-BBD23AE50CDFQ34470451-59ACA7BA-5AF6-49CE-8D6D-CB89D1625B95Q34504572-A5110E4C-8FA7-4B1E-91DD-7B6B078FD927Q34637342-16C8E455-6447-448B-A406-1BF3084BEAF5Q35758909-8F04ED56-15FC-4D33-BC9A-EBCE5CEDF4A1Q35768736-D2203DA2-AD2A-4404-B6D8-B52F593ED35DQ35810679-C354878C-5099-4D08-BE12-AAA01D393E84Q35917813-E57CE702-02CF-47F3-8DF0-14D2110693D5Q36352011-9A6E6EDB-8F10-47E6-BFBB-D9A547E83945Q36732584-DE4F8BB7-463E-405C-BD88-B5D54BE4706FQ37146138-7A836F25-030B-48AE-907B-B949DE37F71FQ37247753-CF68FAEB-533D-49F1-BDAD-45DC5EB8E133Q37522854-47E3C141-8EAA-45DA-9772-CAC3F6ED348AQ37533151-58188EDC-C911-4819-A60C-04ADDF0BD442Q37862940-F32AC2E6-E497-48C6-B86E-4CB367467637Q38061499-5BA612CB-BC16-434B-A25F-BC4F03F412C6Q38192849-ED8E5536-EB2A-45C7-86A4-26F23FB71383Q42425263-603EAA92-62D3-4166-BAFD-4CFB45AB68DDQ46256076-DAD2BC4F-1D1F-44A4-B310-B2858AE407A4Q46835198-F90A36B1-A592-4A9A-8664-97FABDC096A2Q50989985-1DDE5532-2A43-432E-9C0E-93D6A7D81537Q51727409-ADDC847E-F7EC-4EEB-A868-B42FC9420878Q52563096-ED426CA2-67C3-46A0-BB2E-ECC51BFD795DQ52927081-6F915447-75DA-4AC5-AB90-61D7D349EFD1Q54920287-DD9F88E3-773D-4B7A-8110-A95718613F78Q55365280-B9945853-9488-405F-A52F-F9F5DF6A3E23
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Erythropoietin mimics ischemic preconditioning.
@ast
Erythropoietin mimics ischemic preconditioning.
@en
type
label
Erythropoietin mimics ischemic preconditioning.
@ast
Erythropoietin mimics ischemic preconditioning.
@en
prefLabel
Erythropoietin mimics ischemic preconditioning.
@ast
Erythropoietin mimics ischemic preconditioning.
@en
P1476
Erythropoietin mimics ischemic preconditioning.
@en
P2093
John E Baker
P304
P356
10.1016/J.VPH.2005.02.004
P577
2005-03-17T00:00:00Z